newsfilter
← Latest News
GlobeNewswire·

Atea Pharmaceuticals Issues Statement Regarding Director Nominations

BOSTON, March 21, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) (Atea or Company) a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics